Orgenesis Inc.
ORGS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $145,039 | $489,378 | $699,081 | $959,414 |
| - Cash | $837 | $5,311 | $5,473 | $44,923 |
| + Debt | $22,621 | $20,272 | $11,840 | $12,907 |
| Enterprise Value | $166,823 | $504,339 | $705,448 | $927,398 |
| Revenue | $530 | $36,025 | $35,502 | $7,652 |
| % Growth | -98.5% | 1.5% | 364% | – |
| Gross Profit | -$5,725 | $15,585 | $7,342 | -$23,447 |
| % Margin | -1,080.2% | 43.3% | 20.7% | -306.4% |
| EBITDA | -$60,718 | -$8,158 | -$15,718 | -$94,207 |
| % Margin | -11,456.2% | -22.6% | -44.3% | -1,231.1% |
| Net Income | -$55,361 | -$14,889 | -$18,059 | -$95,808 |
| % Margin | -10,445.5% | -41.3% | -50.9% | -1,252.1% |
| EPS Diluted | -1.91 | -0.59 | -0.74 | -4.46 |
| % Growth | -223.7% | 20.3% | 83.4% | – |
| Operating Cash Flow | -$14,837 | -$24,924 | -$26,866 | -$78,046 |
| Capital Expenditures | -$2,096 | -$12,416 | -$7,866 | -$1,525 |
| Free Cash Flow | -$16,933 | -$37,340 | -$34,732 | -$79,571 |